• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Discovery of innovative molecular targeted drugs based on Cancer Cell Informatics

Research Project

Project/Area Number 22240092
Research Category

Grant-in-Aid for Scientific Research (A)

Allocation TypeSingle-year Grants
Section一般
Research Field Clinical oncology
Research InstitutionJapanese Foundation For Cancer Research

Principal Investigator

YAMORI Takao  公益財団法人がん研究会, がん化学療法センター分子薬理部, 客員研究員 (60200854)

Co-Investigator(Kenkyū-buntansha) DAN Shingo  公益財団法人がん研究会, がん化学療法センター・分子薬理部, 副部長 (70332202)
Co-Investigator(Renkei-kenkyūsha) KAWADA Manabu  公益財団法人微生物化学研究会, 微生物化学研究センター・沼津創薬医科学研究所・創薬基盤研究ユニット, ユニット長 (20300808)
NAKAMURA Hiroyuki  学習院大学, 理学部, 教授 (30274434)
SHIINA Isamu  東京理科大学, 理学部, 教授 (40246690)
KOJIMA Naoto  京都薬科大学, 創薬科学系・薬品製造学, 講師 (90420413)
HIRONO Syuichi  北里大学, 薬学部, 教授 (30146328)
Project Period (FY) 2010 – 2012
Project Status Completed (Fiscal Year 2012)
Budget Amount *help
¥50,440,000 (Direct Cost: ¥38,800,000、Indirect Cost: ¥11,640,000)
Fiscal Year 2012: ¥14,430,000 (Direct Cost: ¥11,100,000、Indirect Cost: ¥3,330,000)
Fiscal Year 2011: ¥14,430,000 (Direct Cost: ¥11,100,000、Indirect Cost: ¥3,330,000)
Fiscal Year 2010: ¥21,580,000 (Direct Cost: ¥16,600,000、Indirect Cost: ¥4,980,000)
Keywordsがん治療 / 分子標的薬 / 分子薬理学 / 情報システム
Research Abstract

We improved Cancer Cell Informatics that we originally developed to discover new anticancer drugs, and found a novel anticancer compound AMF-26. It destroyed Golgi apparatus, which controls membrane traffic, and inhibit the growth of cancer cells. AMF-26 induced complete regression of BSY-1 human breast cancer xenograft in nude mice by oral administration. Its toxicity was weak and recoverable. Therefore, AMF-26 is a promising novel anticancer drug candidate targeting Golgi apparatus

Report

(4 results)
  • 2012 Annual Research Report   Final Research Report ( PDF )
  • 2011 Annual Research Report
  • 2010 Annual Research Report
  • Research Products

    (149 results)

All 2013 2012 2011 2010 Other

All Journal Article (57 results) (of which Peer Reviewed: 57 results) Presentation (72 results) (of which Invited: 1 results) Book (16 results) Remarks (1 results) Patent(Industrial Property Rights) (3 results)

  • [Journal Article] Search for Novel Anti-tumor Agents from Ridaifens Using JFCR39, a Panel of Human Cancer Cell Lines2013

    • Author(s)
      Guo WZ, Wang Y, Umeda E, Shiina I, Dan S, Yamori T
    • Journal Title

      Biological and Pharmaceutical Bulletin

      Volume: 36 Issue: 6 Pages: 1008-1016

    • DOI

      10.1248/bpb.b13-00129

    • NAID

      130003361461

    • ISSN
      0918-6158, 1347-5215
    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Cytotoxic Activity of Tivantinib (ARQ 197) Is Not Due Solely to c-MET Inhibition2013

    • Author(s)
      Katayama R, Aoyama A, Yamori T, Qi J, Oh-Hara T, Song Y, Engelman JA, Fujita N
    • Journal Title

      Cancer Res

      Volume: 73(10) Issue: 10 Pages: 3087-96

    • DOI

      10.1158/0008-5472.can-12-3256

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Novel tamoxifen derivative Ridaifen-B induces Bcl-2 independent autophagy without estrogen receptor involvement2013

    • Author(s)
      Nagahara Y, Takeyoshi M, Sakemoto S, Shiina I, Nakata K, Fujimori K, Wang Y, Umeda E, Watanabe C, Uetake S, Yamori T, Dan S, Yoshimi Y, Shinomiya T, Ikekita M
    • Journal Title

      Biochem Biophys Res Commun

      Volume: 435(4) Issue: 4 Pages: 657-63

    • DOI

      10.1016/j.bbrc.2013.05.040

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Total synthesis of AMF-26, an antitumor agent for inhibition of the Golgi system, targeting ADP-ribosylation factor 12013

    • Author(s)
      Shiina I, Umezaki Y, Ohashi Y, Yamazaki Y, Dan S, Yamori T
    • Journal Title

      J Med Chem

      Volume: 56(1) Issue: 1 Pages: 150-159

    • DOI

      10.1021/jm301695c

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Identification of transporters associated with Etoposide sensitivity of stomach cancer cell lines and methotrexate sensitivity of breast cancer cell lines by quantitative targeted absolute proteomics2013

    • Author(s)
      Obuchi W, Ohtsuki S, Uchida Y, Ohmine K, Yamori T, Terasaki T
    • Journal Title

      Mol Pharmacol

      Volume: 83(2) Issue: 2 Pages: 490-500

    • DOI

      10.1124/mol.112.081083

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles2013

    • Author(s)
      Komeda S, Takayama H, Suzuki T, Odani A, Yamori T, Chikuma M
    • Journal Title

      Metallomics

      Volume: 5(5) Issue: 5 Pages: 461-468

    • DOI

      10.1039/c3mt00040k

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Structure-activity relationships of hybrid annonaceous acetogenins: Powerful growth inhibitory effects of their connecting groups between heterocycle and hydrophobic carbon chain bearing THF ring on human cancer cell lines2013

    • Author(s)
      Kojima N, Fushimi T, Tatsukawa T, Yoshimitsu T, Tanaka T, Yamori T, Dan S, Iwasaki H, Yamashita M
    • Journal Title

      Eur J Med Chem

      Volume: 63C Pages: 833-839

    • DOI

      10.1016/j.ejmech.2013.03.009

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Search for Novel Anti-tumor Agents from Ridaifens Using JFCR39, a Panel of Human Cancer Cell Lines.2013

    • Author(s)
      Guo WZ, Wang Y, Umeda E, Shiina I, Dan S, Yamori T.
    • Journal Title

      Biol Pharm Bull.

      Volume: in press

    • NAID

      130003361461

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Cytotoxic Activity of Tivantinib (ARQ 197) Is Not Due Solely to c-MET Inhibition.2013

    • Author(s)
      Katayama R, Aoyama A, Yamori T, Qi J, Oh-Hara T, Song Y, Engelman JA, Fujita N.
    • Journal Title

      Cancer Res.

      Volume: in press

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Novel tamoxifen derivative Ridaifen-B induces Bcl-2 independent autophagy without estrogen receptor involvement.2013

    • Author(s)
      Takeyoshi M, Sakemoto S, Shiina I, Nakata K, Fujimori K, Wang Y, Umeda E, Watanabe C, Uetake S, Yamori T, Dan S, Yoshimi Y, Shinomiya T, Ikekita M.
    • Journal Title

      Biochem Biophys Res Commun.

      Volume: in press

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Development of a gene expression database and related analysis programs for evaluation of anticancer compounds.2013

    • Author(s)
      Ushijima M, Mashima T, Tomida A, Dan S, Saito S, Furuno A, Tsukahara S, Seimiya H, Yamori T, Matsuura M.
    • Journal Title

      Cancer Sci.

      Volume: 104(3) Issue: 3 Pages: 360-368

    • DOI

      10.1111/cas.12071

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Total synthesis of bicyclic depsipeptides spiruchostatins C and D and investigation of their histone deacetylase inhibitory and antiproliferative activities.2013

    • Author(s)
      Narita K, Fukui Y, Sano Y, Yamori T, Ito A, Yoshida M, Katoh T.
    • Journal Title

      Eur J Med Chem.

      Volume: 60 Pages: 295-304

    • DOI

      10.1016/j.ejmech.2012.12.023

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Disruption of Tacc3 function leads to in vivo tumor regression2012

    • Author(s)
      Yao R, Natsume Y, Saiki Y, Shioya H, Takeuchi K, Yamori T, Toki H, Aoki I, Saga T, Noda T.
    • Journal Title

      Oncogene

      Volume: 31(2) Issue: 2 Pages: 135-48

    • DOI

      10.1038/onc.2011.235

    • Related Report
      2012 Annual Research Report 2012 Final Research Report 2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] AMF-26, a Novel Inhibitor of the Golgi System, Targeting ADP-ribosylation Factor 1 (Arf1) with Potential for Cancer Therapy2012

    • Author(s)
      Ohashi Y, Iijima H, Yamaotsu N, Yamazaki K, Sato S, Okamura M, Sugimoto K, Dan S, Hirono S, Yamori T
    • Journal Title

      J Biol Chem

      Volume: 287(6) Issue: 6 Pages: 3885-3897

    • DOI

      10.1074/jbc.m111.316125

    • Related Report
      2012 Annual Research Report 2012 Final Research Report 2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Isolation and structures of biselyngbyasides B, C, and D from the marine cyanobacterium Lyngbya sp., and the biological activities of biselyngbyasides2012

    • Author(s)
      M. Morita, O. Ohno, T. Teruya, T. Yamori, T. Inuzuka, K. Suenaga
    • Journal Title

      Tetrahedron

      Volume: 68 Issue: 30 Pages: 5984-5990

    • DOI

      10.1016/j.tet.2012.05.038

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs2012

    • Author(s)
      Kong D, Yamori T
    • Journal Title

      Bioorg Med Chem

      Volume: 20(6) Issue: 6 Pages: 1947-1951

    • DOI

      10.1016/j.bmc.2012.01.017

    • Related Report
      2012 Annual Research Report 2012 Final Research Report 2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Cleavage mechanism and anti-tumor activity of 3,6-epidioxy-1,10-bisaboladiene isolated from edible wild plants2012

    • Author(s)
      Kimura KI, Sakamoto Y, Fujisawa N, Uesugi S, Aburai N, Kawada M, Ohba SI, Yamori T, Tsuchiya E, Koshino H
    • Journal Title

      Bioorg Med Chem

      Volume: 20(12) Issue: 12 Pages: 3887-3897

    • DOI

      10.1016/j.bmc.2012.04.025

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Development of an Immunohistochemical Protein Quantification System in Conjunction with Tissue Microarray Technology for Identifying Predictive Biomarkers for Phosphatidylinositol 3-Kinase Inhibitors2012

    • Author(s)
      Isoyama S, Yoshimi H, Dan S, Okamura M, Seki M, Irimura T, Yamori T
    • Journal Title

      Biological and Pharmaceutical Bulletin

      Volume: 35 Issue: 9 Pages: 1607-1613

    • DOI

      10.1248/bpb.b12-00327

    • NAID

      130001872078

    • ISSN
      0918-6158, 1347-5215
    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Establishment of phosphatidylinositol 3-kinase inhibitor-resistant cancer cell lines and therapeutic strategies for overcoming the resistance2012

    • Author(s)
      Isoyama S, Dan S, Nishimura Y, Nakamura N, Kajiwara G, Seki M, Irimura T, Yamori T
    • Journal Title

      Cancer Sci

      Volume: 103(11) Issue: 11 Pages: 1955-1960

    • DOI

      10.1111/cas.12004

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] ZSTK474, a specific phosphatidylinositol 3-kinase inhibitor, induces G1 arrest of the cell cycle in vivo2012

    • Author(s)
      Dan S, Okamura M, Mukai Y, Yoshimi H, Inoue Y, Hanyu A, Sakaue-Sawano A, Imamura T, Miyawaki A, Yamori T
    • Journal Title

      Eur J Cancer

      Volume: 48(6) Issue: 6 Pages: 936-943

    • DOI

      10.1016/j.ejca.2011.10.006

    • Related Report
      2012 Annual Research Report 2012 Final Research Report 2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Potentiation of Bleomycin in Jurkat Cells by Fungal Pycnidione2012

    • Author(s)
      Kaneko M, Matsuda D, Ohtawa M, Fukuda T, Nagamitsu T, Yamori T, Tomoda H.
    • Journal Title

      Biological and Pharmaceutical Bulletin

      Volume: 35 Issue: 1 Pages: 18-28

    • DOI

      10.1248/bpb.35.18

    • NAID

      130001872337

    • ISSN
      0918-6158, 1347-5215
    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Inhibitory effects of ZSTK474, a phosphatidylinositol 3-kinase inhibitor, on adjuvant-induced arthritis in rats.2012

    • Author(s)
      Haruta K, Mori S, Tamura N, Sasaki A, Nagamine M, Yaguchi S, Kamachi F, Enami J, Kobayashi S, Yamori T, Takasaki Y.
    • Journal Title

      Inflamm Res.

      Volume: 61(6) Issue: 6 Pages: 551-562

    • DOI

      10.1007/s00011-012-0444-8

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Inhibitory effects of ZSTK474, a phosphatidylinositol 3-kinase inhibitor, on adjuvant-induced arthritis in rats2012

    • Author(s)
      Haruta K, Mori S, Tamura N, Sasaki A, Nagamine M, Yaguchi SI, Kamachi F, Enami J, Kobayashi S, Yamori T, Takasaki Y
    • Journal Title

      Inflamm Res

      Volume: (in press)

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Improving drug potency and efficacy by nanocarrier-mediated subcellular targeting2011

    • Author(s)
      M. Murakami, H. Cabral, Y. Matsumoto, S. Wu, M. R. Kano, T. Yamori, N. Nishiyama, K. Kataoka
    • Journal Title

      Science Transl. Med

      Volume: 3(64) Issue: 64 Pages: 64-64

    • DOI

      10.1126/scitranslmed.3001385

    • Related Report
      2012 Final Research Report 2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Design and synthesis of C35-fluorinated solamins and their growth inhibitory activities against human cancer cell lines2011

    • Author(s)
      Naoto Kojima
    • Journal Title

      Bioorg. Med. Chem. Lett.

      Volume: 21 Issue: 19 Pages: 5745-5749

    • DOI

      10.1016/j.bmcl.2011.08.011

    • Related Report
      2012 Final Research Report 2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Total synthesis of (-)-brevenal : A streamlined strategy for practical synthesis of polycyclic ethers2011

    • Author(s)
      M.Ebine, H.Fuwa, M.Sasaki
    • Journal Title

      Chemistry-A European Journal

      Volume: 17(in press) Issue: 9 Pages: 2678-2688

    • DOI

      10.1002/chem.201003135

    • Related Report
      2012 Final Research Report 2011 Annual Research Report 2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Effectiveness of combined treatment using X-rays and a phosphoinositide 3-kinase inhibitor, ZSTK474, on proliferation of HeLa cells in vitro and in vivo2011

    • Author(s)
      Anzai K, Sekine-Suzuki E, Ueno M, Okamura M, Yoshimi H, Dan S, Yaguchi S, Enami J, Yamori T, Okayasu R
    • Journal Title

      Cancer Sci

      Volume: 102(6) Pages: 1176-1180

    • NAID

      10029294463

    • Related Report
      2012 Final Research Report 2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Telomestatin Impairs Glioma Stem Cell Survival and Growth through the Disruption of Telomeric G-Quadruplex and Inhibition of the Proto-oncogene, c-Myb2011

    • Author(s)
      Miyazaki T, Pan Y, Joshi K, Purohit D, Hu B, Demir H, Mazumder S, Okabe S, Yamori T, Viapiano M, Shin-Ya K, Seimiya H, Nakano I
    • Journal Title

      Clin Cancer Res

      Volume: 18(5) Issue: 5 Pages: 1268-1280

    • DOI

      10.1158/1078-0432.ccr-11-1795

    • Related Report
      2012 Annual Research Report 2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Potentiation of bleomycin in jurkat cells by fungal pycnidione2011

    • Author(s)
      Kaneko M, Matsuda D, Ohtawa M, Fukuda T, Nagamitsu T, Yamori T, Tomoda H
    • Journal Title

      Biol Pharm Bull

      Volume: 35(1) Pages: 18-28

    • NAID

      130001872337

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Inhibitory Activity of Flavonoids against Class I Phosphatidylinositol 3-Kinase Isoforms2011

    • Author(s)
      Kong D, Zhang Y, Yamori T, Duan H, Jin M
    • Journal Title

      Molecules

      Volume: 16(6) Issue: 6 Pages: 5159-5167

    • DOI

      10.3390/molecules16065159

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Antiproliferative and antiangiogenic activities of smenospongine, a marine sponge sesquiterpene aminoquinone2011

    • Author(s)
      Kong D, Yamori T, Kobayashi M, Duan H
    • Journal Title

      Mar Drugs

      Volume: 9(2) Issue: 2 Pages: 154-161

    • DOI

      10.3390/md9020154

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Transient PI3K inhibition induces apoptosis and overcomes HGF-mediated resistance to EGFR-TKIs in EGFR mutant lung cancer2011

    • Author(s)
      Donev IS, Wang W, Yamada T, Li Q, Takeuchi S, Matsumoto K, Yamori T, Nishioka Y, Sone S, Yano S
    • Journal Title

      Clin Cancer Res

      Volume: 17 Issue: 8 Pages: 2260-9

    • DOI

      10.1158/1078-0432.ccr-10-1993

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Identification of chrysoplenetin from Vitex negundo as a potential cytotoxic agent against PANC-1 and a panel of 39 human cancer cell lines (JFCR-39)2011

    • Author(s)
      Awale S, Linn TZ, Li F, Tezuka Y, Myint A, Tomida A, Yamori T, Esumi H, Kadota S
    • Journal Title

      Phytother Res

      Volume: 25(12) Issue: 12 Pages: 1770-1775

    • DOI

      10.1002/ptr.3441

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Transient P13K Inhibition Induces Apoptosis and Overcomes HGF-Mediated Resistance to EGFR-TKIs in EGFR Mutant Lung Cancer.2011.2011

    • Author(s)
      Donev IS, Wang W, Yamada T, LiQ, Takeuchi S, Matsumoto K, Yamori T, Nishioka Y, Sone S, Yano S.
    • Journal Title

      Clin Cancer Res

      Volume: in press

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Effectiveness of combined treatment using X-rays and a phosphoinositide 3-kinase inhibitor, ZSTK474, on proliferation of HeLa cells in vitro and invivo.2011

    • Author(s)
      Anzai K, Sekine-Suzuki E, Ueno M, Okamura M, Yoshimi H, Dan S, Yaguchi SI, Enami J, Yamori T, Okayasu R.
    • Journal Title

      Cancer Sci

      Volume: in press

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Cytochrome P450 1B1 gene polymorphisms as predictors of anticancer drug activity: studies with in vitro models2010

    • Author(s)
      Laroche-Clary A, Le Morvan V, Yamori T, Robert J
    • Journal Title

      Mol Cancer Ther

      Volume: 9(12) Issue: 12 Pages: 3315-3321

    • DOI

      10.1158/1535-7163.mct-10-0673

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor identified using the JFCR39 drug discovery system2010

    • Author(s)
      Kong DX, Yamori T
    • Journal Title

      Acta Pharmacol Sin

      Volume: 31(9) Issue: 9 Pages: 1189-1197

    • DOI

      10.1038/aps.2010.150

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Discovery of phosphatidylinositol 3-kinase inhibitory compounds from the Screening Committee of Anticancer Drugs (SCADS) library2010

    • Author(s)
      Kong D, Yamazaki K, Yamori T
    • Journal Title

      Biol Pharm Bull

      Volume: 33(9) Pages: 1600-1604

    • NAID

      130000322363

    • URL

      https://www.jstage.jst.go.jp/article/bpb/33/9/33_9_1600/_article

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Inhibition profiles of phosphatidylinositol 3-kinase inhibitors against PI3K superfamily and human cancer cell line panel JFCR392010

    • Author(s)
      Kong D, Dan S, Yamazaki K, Yamori T
    • Journal Title

      Eur J Cancer

      Volume: 46(6) Issue: 6 Pages: 1111-1121

    • DOI

      10.1016/j.ejca.2010.01.005

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Convergent synthesis of fluorescence-labeled probes of Annonaceous acetogenins and visualization of their cell distribution2010

    • Author(s)
      Kojima N, Morioka T, Urabe D, Yano M, Suga Y, Maezaki N, Ohashi-Kobayashi A, Fujimoto Y, Maeda M, Yamori T, Yoshimitsu T, Tanaka T
    • Journal Title

      Bioorg Med Chem

      Volume: 18(24) Issue: 24 Pages: 8630-8641

    • DOI

      10.1016/j.bmc.2010.10.004

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Ishikawa Y, Yamori T. Correlating phosphatidylinositol 3-kinase inhibitor efficacy with signaling pathway status: in silico and biological evaluations2010

    • Author(s)
      Dan S, Okamura M, Seki M, Yamazaki K, Sugita H, Okui M, Mukai Y, Nishimura H, Asaka R, Nomura K, Ishikawa Y, Yamori T
    • Journal Title

      Cancer Res

      Volume: 70(12) Issue: 12 Pages: 4982-4994

    • DOI

      10.1158/0008-5472.can-09-4172

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Synthesis and preclinical evaluations of 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one monosodium phosphate (CHM-1-P-Na) as a potent antitumor agent2010

    • Author(s)
      Chou LC, Chen CT, Lee JC, Way TD, Huang CH, Huang SM, Teng CM, Yamori T, Wu TS, Sun CM, Chien DS, Qian K,Morris-Natschke SL, Lee KH, Huang LJ, Kuo SC
    • Journal Title

      J Med Chem

      Volume: 53(4) Issue: 4 Pages: 1616-1626

    • DOI

      10.1021/jm901292j

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Improving drug potency and efficacy by nanocarrier-mediated subcellular targeting.2010

    • Author(s)
      Murakami M, Cabral H, Matsumoto Y, Wu S, Kano MR, Yamori T, Nishiyama N, Kataoka K.
    • Journal Title

      Sci Transl Med

      Volume: 3(64)

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Triterpene glycosides from Curculigo orchioides and their cytotoxic activity.2010

    • Author(s)
      Yokosuka A, Sato K, Yamori T, Mimaki Y.
    • Journal Title

      J Nat Prod

      Volume: 73(6) Pages: 1102-1106

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Yaku'amides A and B, cytotoxic linear peptides rich in dehydroamino acids from the marine sponge Ceratopsion sp.2010

    • Author(s)
      Ueoka R, Ise Y, Ohtsuka S, Okada S, Yamori T, Matsunaga S.
    • Journal Title

      J Am Chem Soc

      Volume: 132(50) Pages: 17692-17694

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Inhibitory effects of ZSTK474, a novel phosphoinositide 3-kinase inhibitor, on osteoclasts and collagen-induced arthritis in mice.2010

    • Author(s)
      Toyama S, Tamura N, Haruta K, Karakida T, Mori S, Watanabe T, Yamori T, Takasaki Y.
    • Journal Title

      Arthritis Res Ther

      Volume: 12(3)

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Mitochondrial inhibitors show preferential cytotoxicity to human pancreatic cancer PANG-1 cells under glucose-deprived conditions.2010

    • Author(s)
      Momose I, Ohba S, Tatsuda D, Kawada M, Masuda T, Tsujiuchi G, Yamori T, Esumi H, Ikeda D.
    • Journal Title

      Biochem Biophys Res Commun

      Volume: 392(3) Pages: 460-466

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Cytochrome P450 1B1 gene polymorphisms as predictors of anticancer drug activity : studies with in vitro models.2010

    • Author(s)
      Laroche-Clary A, Le Morvan V, Yamori T, Robert J.
    • Journal Title

      Mol Cancer Ther

      Volume: 9(12) Pages: 3315-3321

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Correlation between cytotoxic activities and reduction potentials of heterocyclic quinones.2010

    • Author(s)
      Koyama J, Morita I, Yamori T.
    • Journal Title

      Molecules

      Volume: 15(9) Pages: 6559-6569

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor identified using the JFCR39 drug discovery system.2010

    • Author(s)
      Kong DX, Yamori T.
    • Journal Title

      Acta Pharmacol Sin

      Volume: 31(9) Pages: 1189-1197

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Discovery of Phosphatidylinositol 3-Kinase inhibitory compounds from the Screening Committee of Anticancer Drugs (SCADS) library.2010

    • Author(s)
      Kong D, Yamazaki K, Yamori T.
    • Journal Title

      Biol Pharm Bull

      Volume: 33(9) Pages: 1600-1604

    • NAID

      130000322363

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Inhibition profiles of phosphatidylinositol 3-kinase inhibitors against P13K superfamily and human cancer cell line panel JFCR39.2010

    • Author(s)
      Kong D, Dan S, Yamazaki K, Yamori T.
    • Journal Title

      Eur J Cancer

      Volume: 46(6) Pages: 1111-1121

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Convergent synthesis of fluorescence-labeled probes of Annonaceous acetogenins and visualization of their cell distribution.2010

    • Author(s)
      Kojima N, Morioka T, Urabe D, Yano M, Suga Y, Maezaki N, Ohashi-Kobayashi A, Fujimoto Y, Maeda M, Yamori T, Yoshimitsu T, Tanaka T.
    • Journal Title

      Bioorg Med Chem

      Volume: 18(24) Pages: 8630-8641

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] The G protein-coupled receptor T-cell death-associated gene 8 (TDAG8)facilitates tumor development by serving as an extracellular pH sensor.2010

    • Author(s)
      Ihara Y, Kihara Y, Hamano F, Yanagida K, Morishita Y, Kunita A, Yamori T, Fukayama M, Aburatani H, Shimizu T, Ishii S.
    • Journal Title

      Proc Natl Acad Sci USA.

      Volume: 107(40) Pages: 17309-17314

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Activation status of receptor tyrosine kinase downstream pathways in primary lung adenocarcinoma with reference of KRAS and EGFR mutations.2010

    • Author(s)
      Hiramatsu M, Ninomiya H, Inamura K, Nomura K, Takeuchi K, Satoh Y, Okumura S, Nakagawa K, Yamori T, Matsuura M, Morikawa T, Ishikawa Y.
    • Journal Title

      Lung Cancer

      Volume: 70(1) Pages: 94-102

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Correlating phosphatidylinositol 3-kinase inhibitor efficacy with signaling pathway status : in silico and biological evaluations.2010

    • Author(s)
      Dan S, Okamura M, Seki M, Yamazaki K, Sugita H, Okui M, Mukai Y, Nishimura H, Asaka R, Nomura K, Ishikawa Y, Yamori T.
    • Journal Title

      Cancer Res.

      Volume: 70(12) Pages: 4982-4994

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Synthesis and preclinical evaluations of 2-(2-fluorophenyl)-6, 7-methylenedioxyquinolin-4-one monosodium phosphate(CHM-1-P-Na) as a potent antitumor agent.2010

    • Author(s)
      Chou LC, Chen CT, Lee JC, Way TD, Huang CH, Huang SM, Teng CM, Yamori T, Wu TS, Sun CM, Chien DS, Qian K, Morris-Natschke SL, Lee KH, Huang LJ, Kuo SC.
    • Journal Title

      J Med Chem

      Volume: 53(4) Pages: 1616-1626

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Presentation] Identification of IGF1R as a responsible gene and a therapeutic target for acquired and intrinsic resistance to PI3K inhibitors2013

    • Author(s)
      Dan S, Isoyama S, Nishimura Y, Nakamura N, Tamaki N, Yamori T
    • Organizer
      第9回(2013年)日米がん合同会議
    • Place of Presentation
      USA・ハワイ
    • Related Report
      2012 Annual Research Report
  • [Presentation] Cancer Cell Informaticsとは-分子標的薬探索における有用性-2012

    • Author(s)
      矢守隆夫
    • Organizer
      先端創薬科学講座セミナーコース2012
    • Place of Presentation
      東京
    • Year and Date
      2012-01-06
    • Related Report
      2011 Annual Research Report
  • [Presentation] Identification of a new inhibitor of the Golgi system, targeting ADP-ribosylation Factor 1 (Arf1) with potential for cancer therapy2012

    • Author(s)
      Ohashi Y, Iijima H, Yamaotsu N, Yamazaki K, Sato S, Okamura M, Sugimoto K, Dan S, Hirono S, Yamori T
    • Organizer
      2012AACR Annual Meeting
    • Place of Presentation
      Chicago, USA
    • Related Report
      2012 Final Research Report
  • [Presentation] Discovery of Molecular-Targeted Drugs by an information-rich Cancer Cell Line Panel2012

    • Author(s)
      Yamori T
    • Organizer
      "JFCR39 ". 理研・マックスプランク研究所合同シンポジウム
    • Place of Presentation
      ドイツ
    • Related Report
      2012 Final Research Report
  • [Presentation] A Novel Golgi Disruptor, AMF-26, Targets ADP-ribosylation Factor 1 (Arf1) with Potential for Cancer Therapy2012

    • Author(s)
      Ohashi Y, Iijima H, Yamaotsu N, Yamazaki K, Okamura M, Sugimoto K, Hirono S, Dan S, Yamori T
    • Organizer
      The 17thJapanese Foundation for Cancer Research International Symposium on Cancer Chemotherapy (ISCC)
    • Place of Presentation
      東京
    • Related Report
      2012 Annual Research Report
  • [Presentation] Identification of IGF1R as a responsible factor for acquired resistance to PI3K inhibitors2012

    • Author(s)
      Isoyama S, Dan S, Nishimura Y, Kajiwara G, Irimura T, Yamori T
    • Organizer
      The 17thJapanese Foundation for Cancer Research International Symposium on Cancer Chemotherapy (ISCC)
    • Place of Presentation
      東京
    • Related Report
      2012 Annual Research Report
  • [Presentation] Identification of IGF1R as a Predictive Biomarker for Intrinsic Resistance to PI3K Inhibitors and a Therapeutic Target for Improving the Drug Efficacy2012

    • Author(s)
      Dan S, Isoyama S, Nishimura Y, Kajiwara G, Nakamura N, Yamori T
    • Organizer
      EORTC-NCI-AACR Symposium
    • Place of Presentation
      Ireland Dublin
    • Related Report
      2012 Annual Research Report
  • [Presentation] Development of a Novel Inhibitor of ADP-ribosylation Factor 1 (Arf1) That Has Potential for Cancer Therapy2012

    • Author(s)
      Ohashi Y, Ijima H, Yamaotsu N, Yamazaki K, Okamura M, Sugimoto K, Hirono S, Dan S, Yamori T
    • Organizer
      EORTC-NCI-AACR Symposium
    • Place of Presentation
      Ireland Dublin
    • Related Report
      2012 Annual Research Report
  • [Presentation] ZSTK474, a specific PI3K inhibitor, induces mesenchymal to epithelial transition in vivo2012

    • Author(s)
      Okamura M, Dan S, Yoshimi H,Yamori T
    • Organizer
      EORTC-NCI-AACR Symposium
    • Place of Presentation
      Ireland Dublin
    • Related Report
      2012 Annual Research Report
  • [Presentation] Establishment of PI3K Inhibitor-resistant Cancer Cell Lines and the Therapeutic Strategies for Overcoming the Acquired Resistance2012

    • Author(s)
      Isoyama S, Dan S, Nishimura Y, Kajiwara G, Nakamura N, Irimura T, Yamori T
    • Organizer
      EORTC-NCI-AACR Symposium
    • Place of Presentation
      Ireland Dublin
    • Related Report
      2012 Annual Research Report
  • [Presentation] PI3K阻害剤の治療抵抗性に関わるIGF1Rの過剰発現とそれを標的とした治療戦略2012

    • Author(s)
      旦慎吾、礒山翔、西村由美子、梶原玄誠、 矢守隆夫
    • Organizer
      第71回日本癌学会
    • Place of Presentation
      札幌
    • Related Report
      2012 Annual Research Report
  • [Presentation] 新規ゴルジ阻害剤AMF-26のArf1活性化阻害能と抗腫瘍効果2012

    • Author(s)
      大橋愛美、山崎佳波、佐藤重男、岡村睦美、 杉本憲治、旦慎吾、矢守隆夫
    • Organizer
      第71回日本癌学会
    • Place of Presentation
      札幌
    • Related Report
      2012 Annual Research Report
  • [Presentation] バンレイシ科アセトゲニン誘導体NK-0045の抗腫瘍活性と作用機序2012

    • Author(s)
      赤塚明宣、岡村睦美、小島直人、矢守隆夫
    • Organizer
      第71回日本癌学会
    • Place of Presentation
      札幌
    • Related Report
      2012 Annual Research Report
  • [Presentation] JFCR39パネルを用いたリダイフェン類からの新規抗がん剤の探索2012

    • Author(s)
      郭文智、椎名勇、旦慎吾、矢守隆夫
    • Organizer
      第71回日本癌学会
    • Place of Presentation
      札幌
    • Related Report
      2012 Annual Research Report
  • [Presentation] PI3K阻害剤の獲得耐性に関連するIGF1遺伝子の同定2012

    • Author(s)
      礒山翔、旦慎吾、西村由美子、梶原玄誠、矢守隆夫
    • Organizer
      第71回日本癌学会
    • Place of Presentation
      札幌
    • Related Report
      2012 Annual Research Report
  • [Presentation] PI3K阻害剤の治療抵抗性に関わるIGF1Rの過剰発現とそれを利用した治療戦略2012

    • Author(s)
      旦慎吾、礒山翔、矢守隆夫
    • Organizer
      第16回日本がん分子標的学会
    • Place of Presentation
      北九州
    • Related Report
      2012 Annual Research Report
  • [Presentation] 新規ゴルジ阻害剤AMF-26の作用機序と抗腫瘍効果2012

    • Author(s)
      大橋愛美、岡村睦美、杉本憲治、旦慎吾、矢守隆夫
    • Organizer
      第16回日本がん分子標的学会
    • Place of Presentation
      北九州
    • Related Report
      2012 Annual Research Report
  • [Presentation] PI3K阻害剤長期暴露による獲得耐性細胞の樹立と耐性化に関連する分子の同定2012

    • Author(s)
      礒山翔、旦慎吾、矢守隆夫
    • Organizer
      第16回日本がん分子標的学会
    • Place of Presentation
      北九州
    • Related Report
      2012 Annual Research Report
  • [Presentation] Identification of a new inhibitor of the Golgi system, targeting ADP-ribosylation Factor 1 (Arf1) with potential for cancer therapy2012

    • Author(s)
      Ohashi Y, Iijima H, Yamaotsu N, Yamazaki K, Sato S, Okamura M, Sugimoto K, Dan S, Hirono S, Yamori T
    • Organizer
      2012AACR Annual Meeting
    • Place of Presentation
      USA・シカゴ
    • Related Report
      2012 Annual Research Report
  • [Presentation] ゴルジ阻害剤の探索を目的とした画像解析法の確立2012

    • Author(s)
      山崎勇太、大橋愛美、矢守隆夫
    • Organizer
      日本薬学会第132年会
    • Place of Presentation
      札幌
    • Related Report
      2011 Annual Research Report
  • [Presentation] ZSTK474耐性を克服する併用薬の同定2012

    • Author(s)
      中村直起、旦慎吾、西村由美子、礒山翔、梶原玄誠、矢守隆夫
    • Organizer
      日本薬学会第132年会
    • Place of Presentation
      札幌
    • Related Report
      2011 Annual Research Report
  • [Presentation] Discovery of Molecular-Targeted Drugs by an information-rich Cancer Cell Line Panel "JFCR39"2012

    • Author(s)
      矢守隆夫
    • Organizer
      理研・マックスプランク研究所合同シンポ
    • Place of Presentation
      ドイツ
    • Related Report
      2011 Annual Research Report
  • [Presentation] がん支援・化学療法基盤支援活動の取り組み2011

    • Author(s)
      矢守隆夫
    • Organizer
      合同シンポジウム「わが国における新規抗がん剤開発の諸問題」~産官学連携をどう進めるか
    • Place of Presentation
      東京
    • Year and Date
      2011-11-18
    • Related Report
      2011 Annual Research Report
  • [Presentation] 分子標的薬の現状と展望2011

    • Author(s)
      矢守隆夫
    • Organizer
      第27回薬学講座
    • Place of Presentation
      東京
    • Year and Date
      2011-10-15
    • Related Report
      2011 Annual Research Report
  • [Presentation] 不思議な抗がん物質探索系(Cancer Cell Informatics)の紹介-新しい分子標的薬発見から創薬へ2011

    • Author(s)
      矢守隆夫
    • Organizer
      お茶の水がん学アカデミー第72回集会
    • Place of Presentation
      東京
    • Year and Date
      2011-07-29
    • Related Report
      2011 Annual Research Report
  • [Presentation] 新規化合物の分子標的予測法の開発と応用~新規PI3キナーゼ阻害剤の同定~2011

    • Author(s)
      矢守隆夫
    • Organizer
      BTJプロフェッショナルセミナー
    • Place of Presentation
      東京
    • Year and Date
      2011-06-17
    • Related Report
      2011 Annual Research Report
  • [Presentation] 新規化合物の分子標的予測法の開発と応用-新規PI3キナーゼ阻害剤の同定2011

    • Author(s)
      矢守隆夫
    • Organizer
      第27回日本医工学治療学会
    • Place of Presentation
      岡山
    • Year and Date
      2011-04-23
    • Related Report
      2011 Annual Research Report
  • [Presentation] 未来の分子標的薬はどうやって作られる?2011

    • Author(s)
      旦慎吾
    • Organizer
      がんプロ新潟セミナー
    • Place of Presentation
      新潟
    • Year and Date
      2011-03-05
    • Related Report
      2010 Annual Research Report
  • [Presentation] Cancer Cell Informaticsとは-分子標的薬探索における有用性-2011

    • Author(s)
      矢守隆夫
    • Organizer
      先端創薬科学講座セミナーコース2011
    • Place of Presentation
      東京
    • Year and Date
      2011-01-21
    • Related Report
      2010 Annual Research Report
  • [Presentation] 抗腫瘍活性アセトゲニンの含フッ素アナログの合成と活性評価2011

    • Author(s)
      小島直人、矢守隆夫
    • Organizer
      第70回日本癌学会
    • Place of Presentation
      名古屋
    • Related Report
      2011 Annual Research Report
  • [Presentation] PI3K阻害剤ZSTK474とMEK1/2阻害剤AZD6244の併用による抗腫瘍効果2011

    • Author(s)
      吉見直、西村由美子、岡村睦美、礒山翔、矢守隆夫
    • Organizer
      第70回日本癌学会
    • Place of Presentation
      名古屋
    • Related Report
      2011 Annual Research Report
  • [Presentation] ZSTK474長期間暴露によるPI3K阻害剤耐性の誘導2011

    • Author(s)
      梶原玄誠、西村由美子、旦慎吾、矢守隆夫
    • Organizer
      第70回日本癌学会
    • Place of Presentation
      名古屋
    • Related Report
      2011 Annual Research Report
  • [Presentation] PI3K/Akt/mTOR経路の概略、PI3K阻害剤2011

    • Author(s)
      旦慎吾
    • Organizer
      第9回日本臨床腫瘍学会
    • Place of Presentation
      横浜
    • Related Report
      2011 Annual Research Report
  • [Presentation] PI3K阻害剤とその開発2011

    • Author(s)
      矢守隆夫
    • Organizer
      第9回日本臨床腫瘍学会
    • Place of Presentation
      横浜
    • Related Report
      2011 Annual Research Report
  • [Presentation] 蛍光標識化アセトゲニンの収束的合成法の開発とその細胞内動態2011

    • Author(s)
      小島直人、矢守隆夫
    • Organizer
      第15回日本がん分子標的学会
    • Place of Presentation
      東京
    • Related Report
      2011 Annual Research Report
  • [Presentation] 癌細胞におけるPI3K阻害剤ZSTK474と放射線との併用効果の研究2011

    • Author(s)
      関根絵美子、安西和紀、岡村睦美、吉見直、旦慎吾、矢口信一、榎並淳平、矢守隆夫、岡安隆一
    • Organizer
      第15回日本がん分子標的学会
    • Place of Presentation
      東京
    • Related Report
      2011 Annual Research Report
  • [Presentation] PI3K阻害剤ZSTK474によるin vivo G1アレストの可視化2011

    • Author(s)
      岡村睦美、旦慎吾、吉見直、井上靖道、今村健志、矢守隆夫
    • Organizer
      第15回日本がん分子標的学会
    • Place of Presentation
      東京
    • Related Report
      2011 Annual Research Report
  • [Presentation] ゴルジ阻害剤の探索を目的とした画像解析法の確立2011

    • Author(s)
      大橋愛美、矢守隆夫
    • Organizer
      第15回日本がん分子標的学会
    • Place of Presentation
      東京
    • Related Report
      2011 Annual Research Report
  • [Presentation] Cancer Cell Informaticsを用いたPI3K阻害剤の効果予測バイオマーカーの探索2011

    • Author(s)
      旦慎吾、岡村睦美、矢守隆夫
    • Organizer
      第15回日本がん分子標的学会
    • Place of Presentation
      東京
    • Related Report
      2011 Annual Research Report
  • [Presentation] In vitro and in vivo evaluations of correlation between the activation status of signaling pathways and the efficacy of anticancer compounds in a panel of JFCR39 human cancer cell lines2011

    • Author(s)
      旦慎吾、岡村睦美、関万里子、山崎佳波、向井由美子、矢守隆夫
    • Organizer
      2011AACR Annual Meeting
    • Place of Presentation
      USA・フロリダ
    • Related Report
      2011 Annual Research Report
  • [Presentation] In vivo visualization of GI arrest of the cell cycle induced by a specific PI-3 kinase inhibitor in human tumor xenografts.2011

    • Author(s)
      矢守隆夫、旦慎吾、岡村睦美、向井由美子、吉見直、イノウエヤスミチ、ハニュウアキ、サカウエ-サワノアキコ、今村健志、ミヤワキアツシ
    • Organizer
      Keystone Symposium"PI3-Kinase Signaling Pathways"
    • Place of Presentation
      米国・ボストン
    • Related Report
      2010 Annual Research Report
  • [Presentation] In silico and biological evaluations of correlation between the activation status of signaling pathways and the efficacy of anticancer compounds in apanel of JFCR39 human cancer cell lines.2011

    • Author(s)
      旦慎吾、岡村睦美、関万里子、山崎佳波、向井由美子、矢守隆夫
    • Organizer
      Keystone Symposium
    • Place of Presentation
      米国・ボストン
    • Related Report
      2010 Annual Research Report
  • [Presentation] がんの発生、転移、薬剤耐性2010

    • Author(s)
      矢守隆夫
    • Organizer
      がん専門薬剤師に対する集中講義研修
    • Place of Presentation
      福岡
    • Year and Date
      2010-12-25
    • Related Report
      2010 Annual Research Report
  • [Presentation] Characterization of A New PI3 Kinase Inhibitor ZSTK474.2010

    • Author(s)
      矢守隆圭
    • Organizer
      The 15th Japanese Foundation for Cancer Research International Symposium on Cancer Chemotherapy(ISCC)
    • Place of Presentation
      東京
    • Year and Date
      2010-12-02
    • Related Report
      2010 Annual Research Report
  • [Presentation] がん細胞パネルによる化合物の分子標的予測法(CANCER CELL INFORMATICS):その方法論と分子標的薬開発への応用2010

    • Author(s)
      矢守隆夫
    • Organizer
      ホゾリサーチセンター講演
    • Place of Presentation
      東京
    • Year and Date
      2010-09-10
    • Related Report
      2010 Annual Research Report
  • [Presentation] がん細胞パネルによる化合物の分子標的予測法(CANCER CELL INFORMATICS):その方法論と分子標的薬開発への応用2010

    • Author(s)
      矢守隆夫
    • Organizer
      ゲノム創薬フォーラム第25回談話会
    • Place of Presentation
      東京
    • Year and Date
      2010-07-05
    • Related Report
      2010 Annual Research Report
  • [Presentation] がん細胞パネルによる化合物に分子標的予測法(CANCER CELL INFORMATICS):その方法論と分子標的薬開発への応用2010

    • Author(s)
      矢守隆夫
    • Organizer
      KAN研究所講演
    • Place of Presentation
      神戸
    • Year and Date
      2010-04-13
    • Related Report
      2010 Annual Research Report
  • [Presentation] Identification of a Novel Pi3k Inhibitor for Cancer Treatment2010

    • Author(s)
      Yamori T
    • Organizer
      世界薬学会議 2010 FIP PSWC/AAPS Annual Meeting
    • Place of Presentation
      New Orleans, USA
    • Related Report
      2012 Final Research Report
  • [Presentation] In silico and biological evaluation of correlation between efficacy of PI3K inhibitors with the activation status of signaling pathways in a panel of JFCR39 human cancer cell lines.2010

    • Author(s)
      旦慎吾、岡村睦美、関万里子、山崎佳波、オクイミチヨ、向井由美子、ニシムラヒロユキ、石川雄一、矢守隆夫
    • Organizer
      EORTC-NCI-AACRシンポジウム
    • Place of Presentation
      ドイツ・ベルリン
    • Related Report
      2010 Annual Research Report
  • [Presentation] Identification of a Novel Pi3k Inhibitor for Cancer Treatment.2010

    • Author(s)
      矢守隆夫
    • Organizer
      世界薬学会議2010FIP PSWC/AAPS Annual Meeting
    • Place of Presentation
      米国・ニューオリンズ
    • Related Report
      2010 Annual Research Report
  • [Presentation] Identification of a Novel PI3K Inhibitor for Cancer Treatment.2010

    • Author(s)
      矢守隆夫
    • Organizer
      National Defense Medical Centerからの招待
    • Place of Presentation
      台湾
    • Related Report
      2010 Annual Research Report
  • [Presentation] 座長(EW-15 Molecular target treatment(1))2010

    • Author(s)
      矢守隆夫
    • Organizer
      第69回日本癌学会
    • Place of Presentation
      大阪
    • Related Report
      2010 Annual Research Report
  • [Presentation] PIK3CAIPTEN異常がんにおけるPI3K阻害剤によるG0/G1アレストの誘導2010

    • Author(s)
      旦慎吾、岡村睦美、向井由美子、吉見直、井上靖道、羽生亜紀、今村健志、矢守隆夫
    • Organizer
      第69回日本癌学会
    • Place of Presentation
      大阪
    • Related Report
      2010 Annual Research Report
  • [Presentation] がん細胞パネルに立脚したバイオロジーとインフォマティクスの連携によるPI3K阻害剤の分子薬理解明2010

    • Author(s)
      旦慎吾、矢守隆夫(奨励賞)
    • Organizer
      第69回日本癌学会
    • Place of Presentation
      大阪
    • Related Report
      2010 Annual Research Report
  • [Presentation] Inhibition profiles of novel PI3K inhibitors against PI3K superfamily and human cancer cell line panel JFCR39.2010

    • Author(s)
      孔徳新、矢守隆夫
    • Organizer
      第69回日本癌学会
    • Place of Presentation
      大阪
    • Related Report
      2010 Annual Research Report
  • [Presentation] ゴルジ阻害剤の同定を目的とした画像解析法の確立2010

    • Author(s)
      大橋愛美、矢守隆夫
    • Organizer
      第69回日本癌学会
    • Place of Presentation
      大阪
    • Related Report
      2010 Annual Research Report
  • [Presentation] ヒトがん細胞パネルJFCR39を用いたPI3Kパスウェイ阻害剤のin silico機能評価2010

    • Author(s)
      山崎佳波、旦慎吾、矢守隆夫
    • Organizer
      第69回日本癌学会
    • Place of Presentation
      大阪
    • Related Report
      2010 Annual Research Report
  • [Presentation] ヒトがん細胞パネルJFCR39におけるERBB3発現と薬剤耐性2010

    • Author(s)
      西村由美子、矢守隆夫
    • Organizer
      第69回日本癌学会
    • Place of Presentation
      大阪
    • Related Report
      2010 Annual Research Report
  • [Presentation] PI3K阻害剤によるG0小G1アレストの誘導~in vitroでの評価~2010

    • Author(s)
      向井由美子、旦慎吾、岡村睦美、井上靖道、羽生亜紀、今村健志、矢守隆夫
    • Organizer
      第69回日本癌学会
    • Place of Presentation
      大阪
    • Related Report
      2010 Annual Research Report
  • [Presentation] PI3K阻害剤によるG0/G1アレストの誘導~in vivoでの評価~2010

    • Author(s)
      岡村睦美、旦慎吾、向井由美子、吉見直、井上靖道、羽生亜紀、今村健志、矢守隆夫
    • Organizer
      第69回日本癌学会
    • Place of Presentation
      大阪
    • Related Report
      2010 Annual Research Report
  • [Presentation] JFCR39パネルに基づくバイオマーカー同定のための組織マイクロアレイ開発2010

    • Author(s)
      吉見直、岡村睦美、矢守隆夫
    • Organizer
      第69回日本癌学会
    • Place of Presentation
      大阪
    • Related Report
      2010 Annual Research Report
  • [Presentation] PI3K阻害は、EGFR活性型変異を有する肺癌のHGFによるゲフィチニブ耐性機構を克服する2010

    • Author(s)
      ドネブ イワン シュテレブ、山田忠明、竹内伸司、松本邦夫、矢守隆夫、西岡安彦、曽根三郎、矢野聖二
    • Organizer
      第69回日本癌学会
    • Place of Presentation
      大阪
    • Related Report
      2010 Annual Research Report
  • [Presentation] 低分子分子標的薬の現状と展望-PI3キナーゼ阻害剤を中心に2010

    • Author(s)
      矢守隆夫
    • Organizer
      第14回日本がん分子標的学会
    • Place of Presentation
      東京
    • Related Report
      2010 Annual Research Report
  • [Presentation] PIK3CA-PTEN変異がんに対するZSTK474のG0/G1アレストを介した抗がん効果2010

    • Author(s)
      旦慎吾、向井由美子、井上靖道、今村健志、矢守隆夫
    • Organizer
      第14回日本がん分子標的学会
    • Place of Presentation
      東京
    • Related Report
      2010 Annual Research Report
  • [Presentation] PI3キナーゼ阻害剤ZSTK474とmTOR阻害剤ラパマイシン併用による抗腫瘍効果の増強2010

    • Author(s)
      吉見直、岡村睦美、山崎佳波、矢守隆未
    • Organizer
      第14回日本がん分子標的学会
    • Place of Presentation
      東京
    • Related Report
      2010 Annual Research Report
  • [Presentation] 抗腫瘍活性アセトゲニンの含フッ素アナログの合成と活性評価2010

    • Author(s)
      小島直人、矢守隆夫
    • Organizer
      第14回日本がん分子標的学会
    • Place of Presentation
      東京
    • Related Report
      2010 Annual Research Report
  • [Presentation] カルボラン含有トリアジン類のトポイソメラーゼ阻害活性2010

    • Author(s)
      東海林篤、潘鉉承、矢守隆夫、中村啓之
    • Organizer
      第14回日本がん分子標的学会
    • Place of Presentation
      東京
    • Related Report
      2010 Annual Research Report
  • [Presentation] ブレオマイシン惹起G2期停止を阻害するピクニジオンの作用機序の解析2010

    • Author(s)
      松田大介、矢守隆夫、伴田洋
    • Organizer
      第14回日本がん分子標的学会
    • Place of Presentation
      東京
    • Related Report
      2010 Annual Research Report
  • [Presentation] 癌細胞パネル・インフォマティクスによる毒性オミクスへのアプローチ/The Cancer Cell Panel Informatics for Toxicomics.2010

    • Author(s)
      矢守隆夫
    • Organizer
      第37回日本トキシコロジー学会学術年会
    • Place of Presentation
      沖縄
    • Related Report
      2010 Annual Research Report
  • [Presentation] がん細胞パネルによる化合物の分子標的予測法の開発と創薬への応用(CANCER CELL INFORMATICS)2010

    • Author(s)
      矢守隆夫
    • Organizer
      H22年度日本生化学会関東支部例会
    • Place of Presentation
      長岡
    • Related Report
      2010 Annual Research Report
  • [Presentation] Inhibition of phosphoinositide 3-kinase suppressed growth cancer cells with PIK3CA mutations or loss of PTEN expression via G0/G1 arrest of cell cycle but not apoptosis.2010

    • Author(s)
      旦慎吾、岡村睦美、吉見直、向井由美子、山崎佳波、井上靖道、羽生亜紀、今村健志、坂上(沢野)朝子、宮脇敦史、矢守隆夫
    • Organizer
      2010AACR Annual Meeting
    • Place of Presentation
      米国・ワシントン
    • Related Report
      2010 Annual Research Report
  • [Presentation] わが国における新薬開発の国家戦略 新薬開発に向けたわが国での産官学連携のあり方「規制当局の立場から」

    • Author(s)
      矢守隆夫
    • Organizer
      合同シンポジウム「わが国からの新薬開発を目指して」~医療イノベーションをどう実現するか
    • Place of Presentation
      東京
    • Related Report
      2012 Annual Research Report
    • Invited
  • [Book] 特集・制がん剤の分子標的スクリーニング成績 「化学療法基盤情報支援班」報告-制がん候補物質のスクリーニング成績・第15報-.2013

    • Author(s)
      矢守隆夫, 上原至雅, 深澤秀輔, 吉田稔, 井本正哉, 清宮啓之, 馬島哲夫, 水上民夫, 川田学, 長田裕之, 旦慎吾, 松浦正明, 掛谷秀昭, 冨田章弘.
    • Publisher
      癌と化学療法
    • Related Report
      2012 Annual Research Report
  • [Book] 特集・制がん剤の分子標的スクリーニング成績 「化学療法基盤情報支援班」報告-制がん候補物質のスクリーニング成績・第14報-.2013

    • Author(s)
      矢守隆夫, 上原至雅, 深澤秀輔, 吉田稔, 井本正哉, 清宮啓之, 水上民夫, 川田学, 長田裕之, 松浦正明.
    • Publisher
      癌と化学療法.
    • Related Report
      2012 Annual Research Report
  • [Book] がん細胞パネルによる創薬.2013

    • Author(s)
      矢守隆夫.
    • Publisher
      細胞工学
    • Related Report
      2012 Annual Research Report
  • [Book] JFCR39がん細胞パネルの活用による新たな抗がん剤創薬2012

    • Author(s)
      矢守隆夫, 大橋愛美
    • Publisher
      実験医学
    • Related Report
      2012 Final Research Report
  • [Book] JFCR39がん細胞パネルの活用による新たな抗がん剤創薬.2012

    • Author(s)
      矢守隆夫, 大橋愛美.
    • Publisher
      実験医学.
    • Related Report
      2012 Annual Research Report
  • [Book] アカデミアの立場からの新薬開発支援 がん支援・化学療法基盤支援活動の取り組み.2012

    • Author(s)
      矢守隆夫.
    • Publisher
      腫瘍内科.
    • Related Report
      2012 Annual Research Report
  • [Book] PI3K-Akt-mTOR経路とその阻害剤.2012

    • Author(s)
      旦慎吾, 矢守隆夫.
    • Publisher
      がん分子標的治療.
    • Related Report
      2012 Annual Research Report
  • [Book] 膜小胞輸送にかかわるADPリボシル化因子1の新規阻害剤AMF-26によるゴルジ装置の破壊と抗がん作用.2012

    • Author(s)
      大橋愛美, 矢守隆夫.
    • Publisher
      生体の科学.
    • Related Report
      2012 Annual Research Report
  • [Book] アカデミアの立場からの新薬開発支援がん支援・化学療法基盤支援活動の取り組み.(腫瘍内科「合同シンポジムわが国における新規抗がん剤開発の諸問題:産学連携をどう進めるか」)2012

    • Author(s)
      矢守隆夫
    • Publisher
      科学評論社
    • Related Report
      2011 Annual Research Report
  • [Book] PI3K-Akt-mTOR経路とその阻害剤.(がん分子標的治療「新しいシグナル伝達阻害剤」)2012

    • Author(s)
      旦慎吾、矢守隆夫
    • Publisher
      メディカルビュー社
    • Related Report
      2011 Annual Research Report
  • [Book] JFCR39がん細胞パネルの活用による新たな抗がん剤創薬.(Progress in Medicine「がん分子標的治療の現状と展望」)2012

    • Author(s)
      矢守隆夫, 大橋愛美
    • Publisher
      羊土社
    • Related Report
      2011 Annual Research Report
  • [Book] PI3K/mTOR経路阻害薬(西尾和人編「がん分子標的薬治療の現状と展望」)2011

    • Author(s)
      旦慎吾,矢守隆夫
    • Publisher
      ライフ・サイエンス
    • Related Report
      2011 Annual Research Report
  • [Book] プロテインチップを利用した抗がん剤の作用因子解析(創薬・タンパク質研究のためのプロテオミクス解析・バイオマーカー・標的探索、作用機序解析の研究戦略と実践マニュアル)(小田吉哉・長野光司編)2010

    • Author(s)
      明石哲行, 矢守隆夫
    • Total Pages
      227
    • Publisher
      羊土社
    • Related Report
      2010 Annual Research Report
  • [Book] 特集・制がん剤の分子標的スクリーニング成績「化学療法基盤情報支援班」報告-制がん候補物質のスクリーニング成績・第13報-2010

    • Author(s)
      矢守隆夫, 上原至雅, 吉田稔, 井本正哉, 清宮啓之, 水上民夫, 川田学, 長田裕之, 松浦正明
    • Publisher
      癌と化学療法
    • Related Report
      2010 Annual Research Report
  • [Book] キナーゼ阻害薬2010

    • Author(s)
      矢守隆夫, 孔徳新
    • Publisher
      日本臨林
    • Related Report
      2010 Annual Research Report
  • [Book] PI3キナーゼを標的とした癌治療-PI3K阻害剤開発の現状(分子から個体へと深化する脂質生物学)(佐々木雄彦・横溝岳彦・竹縄忠臣編)2010

    • Author(s)
      矢守隆夫, 孔徳新
    • Total Pages
      235
    • Publisher
      羊土社
    • Related Report
      2010 Annual Research Report
  • [Remarks]

    • URL

      http://www.jfcr.or.jp/laboratory/researcher/2387.html

    • Related Report
      2012 Final Research Report
  • [Patent(Industrial Property Rights)] 『新規化合物及びその製造方法並びに抗がん剤』2012

    • Inventor(s)
      (がん研)矢守隆夫、(東京理科大)椎名勇、中田健也、(東京電機大)長原礼宗
    • Industrial Property Rights Holder
      学校法人 東京理科大学、 学校法人 東京電機大学、 公益財団法人がん研究会
    • Industrial Property Number
      2012-104763
    • Filing Date
      2012-05-06
    • Related Report
      2012 Final Research Report
  • [Patent(Industrial Property Rights)] 『新規化合物及びその製造方法並びに抗がん剤』2012

    • Inventor(s)
      (がん研究会)矢守隆夫、(東京理科大)椎名勇
    • Industrial Property Rights Holder
      学校法人東京理科大学、公益財団法人がん研究会
    • Industrial Property Number
      2012-087973
    • Filing Date
      2012-04-06
    • Related Report
      2012 Final Research Report
  • [Patent(Industrial Property Rights)] ヒトのがん細胞の増殖を抑制するための化合物及び医薬2012

    • Inventor(s)
      がん研究会, 矢守隆夫、岡村睦美/大阪大学, 小島直人、田中徹明、伏見哲也
    • Industrial Property Rights Holder
      がん研究会
    • Industrial Property Number
      2012-008693
    • Filing Date
      2012-01-19
    • Related Report
      2011 Annual Research Report

URL: 

Published: 2010-08-23   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi